UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$552M |
| 2 |
Microsoft
MSFT
|
+$336M |
| 3 |
Accenture
ACN
|
+$230M |
| 4 |
Walmart Inc
WMT
|
+$206M |
| 5 |
Mastercard
MA
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$329M |
| 2 |
CELG
Celgene Corp
CELG
|
+$293M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$220M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$181M |
| 5 |
JPMorgan Chase
JPM
|
+$159M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.8% |
| 2 | Financials | 14.05% |
| 3 | Healthcare | 13.56% |
| 4 | Consumer Discretionary | 12.64% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Insperity
NSP
$2.05B
| $3.69M | ﹤0.01% |
42,837
+2,904
| +7% | +$253K |
|
|
CMD
1277
DELISTED
Cantel Medical Corporation
CMD
| $3.68M | ﹤0.01% |
51,966
+3,585
| +7% | +$260K |
|
1278
BOK Financial
BOKF
$8.74B
| $3.68M | ﹤0.01% |
42,127
+1,725
| +4% | +$141K |
|
1279
Neogen
NEOG
$2.59B
| $3.67M | ﹤0.01% |
112,586
+7,688
| +7% | +$253K |
|
|
AVP
1280
DELISTED
Avon Products, Inc.
AVP
| $3.64M | ﹤0.01% |
644,711
+99,795
| +18% | +$464K |
|
1281
Genworth Financial
GNW
$3.76B
| $3.63M | ﹤0.01% |
825,138
+42,180
| +5% | +$177K |
|
1282
Omnicell
OMCL
$1.71B
| $3.63M | ﹤0.01% |
44,361
+3,142
| +8% | +$241K |
|
1283
Home BancShares
HOMB
$6.27B
| $3.62M | ﹤0.01% |
184,380
+5,100
| +3% | +$96.2K |
|
|
CADE
1284
DELISTED
Cadence Bank
CADE
| $3.61M | ﹤0.01% |
114,948
+6,411
| +6% | +$198K |
|
1285
CNO Financial Group
CNO
$5.16B
| $3.6M | ﹤0.01% |
198,413
+8,273
| +4% | +$141K |
|
1286
Acadia Healthcare
ACHC
$2.85B
| $3.55M | ﹤0.01% |
106,749
+5,836
| +6% | +$183K |
|
1287
Dana Inc
DAN
$2.97B
| $3.53M | ﹤0.01% |
194,143
-2,809
| -1% | -$46.9K |
|
1288
Adient
ADNT
$1.65B
| $3.53M | ﹤0.01% |
166,197
+9,920
| +6% | +$220K |
|
1289
Simpson Manufacturing
SSD
$7.91B
| $3.53M | ﹤0.01% |
44,015
-3,136
| -7% | -$244K |
|
1290
Pegasystems
PEGA
$5.16B
| $3.53M | ﹤0.01% |
88,636
+3,012
| +4% | +$114K |
|
1291
UMB Financial
UMBF
$11.2B
| $3.53M | ﹤0.01% |
51,398
+2,841
| +6% | +$189K |
|
1292
Keurig Dr Pepper
KDP
$42.1B
| $3.52M | ﹤0.01% |
121,717
-14,271
| -10% | -$410K |
|
|
1293
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
| $3.49M | ﹤0.01% |
65,000
-3,504,834
| -98% | -$181M |
|
1294
Pediatrix Medical
MD
$2.16B
| $3.48M | ﹤0.01% |
125,280
+12,545
| +11% | +$315K |
|
1295
GATX Corp
GATX
$6.4B
| $3.48M | ﹤0.01% |
42,016
+648
| +2% | +$52.1K |
|
1296
Cathay General Bancorp
CATY
$4.27B
| $3.48M | ﹤0.01% |
91,432
+5,841
| +7% | +$214K |
|
1297
EnerSys
ENS
$6.88B
| $3.48M | ﹤0.01% |
46,480
+1,149
| +3% | +$79.6K |
|
|
GRTS
1298
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $3.48M | ﹤0.01% |
387,741
-2,818
| -0.7% | -$23.5K |
|
|
B
1299
DELISTED
Barnes Group Inc.
B
| $3.48M | ﹤0.01% |
56,123
+1,113
| +2% | +$64.3K |
|
1300
Nu Skin
NUS
$251M
| $3.47M | ﹤0.01% |
84,725
+10,592
| +14% | +$432K |
|
Similar funds
UBS AM's Q4 2019 Portfolio in Review
As of Q4 2019, UBS AM held 2,974 positions worth $163B, up 10% from $148B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q4 2019 filing shows 83 new, 1,539 increased, 805 reduced and 441 closed positions. Its largest new stake was Pinterest: 348,973 shares worth $6.5M. The largest sale was Vanguard Morningstar Total Stock Market ETF, an estimated $329M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q4 2019 buy was Pinterest: 348,973 shares worth $6.5M.
- UBS AM added most to Alibaba in Q4 2019, an estimated $552M increase.
- UBS AM's biggest Q4 2019 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $181M.
- UBS AM fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2019, selling an estimated $329M.
- UBS AM's ten largest holdings make up 21% of its $163B portfolio in Q4 2019.
- UBS AM opened 83 new positions and closed 441 in Q4 2019.
- UBS AM's portfolio value rose 10% quarter-over-quarter to $163B.
Based on UBS AM's 13F filing for Q4 2019, filed 14 Feb 2020.